Aligned Genetics Balance Sheet Health
Financial Health criteria checks 5/6
Aligned Genetics has a total shareholder equity of ₩33.0B and total debt of ₩2.4B, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are ₩41.2B and ₩8.2B respectively. Aligned Genetics's EBIT is ₩2.6B making its interest coverage ratio -8. It has cash and short-term investments of ₩15.0B.
Key information
7.3%
Debt to equity ratio
₩2.40b
Debt
| Interest coverage ratio | -8x |
| Cash | ₩14.96b |
| Equity | ₩32.99b |
| Total liabilities | ₩8.21b |
| Total assets | ₩41.20b |
Recent financial health updates
No updates
Recent updates
Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit
Nov 20
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price
Aug 12If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late
Apr 06Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years
Feb 11
Financial Position Analysis
Short Term Liabilities: A238120's short term assets (₩21.8B) exceed its short term liabilities (₩1.2B).
Long Term Liabilities: A238120's short term assets (₩21.8B) exceed its long term liabilities (₩7.0B).
Debt to Equity History and Analysis
Debt Level: A238120 has more cash than its total debt.
Reducing Debt: A238120's debt to equity ratio has increased from 0% to 7.3% over the past 5 years.
Debt Coverage: A238120's debt is well covered by operating cash flow (110.5%).
Interest Coverage: A238120 earns more interest than it pays, so coverage of interest payments is not a concern.